CareLit · DOI-Nachweis · Pneumologie
Plasma drug-concentrations in patients with pulmonary arterial hypertension on combination treatment
DOI 10.1055/s-0036-1584623
Bibliografische Angaben
Nachweis in CareLit
Autor:innenE Grünig, J Ohnesorge, N Benjamin, J Burhenne, J Song, B Egenlauf, C Fischer, S Harutyunova, A Huppertz, H Klose, WE Haefeli
ZeitschriftPneumologie
Ausgabe07/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Combination therapy of the phosphodiesterase-type 5 inhibitors (PDE-5i) sildenafil or tadalafil and endothelin receptor antagonists bosentan, ambrisentan, or macitentan may cause mutual pharmacokinetic interactions in patients with pulmonary arterial hypertension (PAH). The objective of this study was to analyse plasma drug concentrations in PAH-patients during different combination treatments. Methods…
Zitieren
Zitierempfehlung
E Grünig, J Ohnesorge, N Benjamin, J Burhenne, J Song, B Egenlauf, C Fischer, S Harutyunova, A Huppertz, H Klose, WE Haefeli (2016) Plasma drug-concentrations in patients with pulmonary arterial hypertension on combination treatment. Pneumologie (07). https://doi.org/10.1055/s-0036-1584623
Mit CareLit weiterarbeiten